94 related articles for article (PubMed ID: 31068650)
1. Uncommon mutational profiles of metastatic colorectal cancer detected during routine genotyping using next generation sequencing.
Franczak C; Kandathil SM; Gilson P; Husson M; Rouyer M; Demange J; Leroux A; Merlin JL; Harlé A
Sci Rep; 2019 May; 9(1):7083. PubMed ID: 31068650
[TBL] [Abstract][Full Text] [Related]
2. KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.
Sanchez-Ibarra HE; Jiang X; Gallegos-Gonzalez EY; Cavazos-González AC; Chen Y; Morcos F; Barrera-Saldaña HA
PLoS One; 2020; 15(7):e0235490. PubMed ID: 32628708
[TBL] [Abstract][Full Text] [Related]
3. Concurrent NRAS-BRAF variants in metastatic colorectal cancer: a Tunisian case report.
Douik H; Sahraoui G; Jemaà M; Doghri R; Charfi L; Mrad K
Anticancer Drugs; 2024 Jun; 35(5):462-465. PubMed ID: 38451831
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of
Georgiou A; Stewart A; Cunningham D; Banerji U; Whittaker SR
Mol Cancer Res; 2020 Jun; 18(6):835-846. PubMed ID: 32098826
[TBL] [Abstract][Full Text] [Related]
5. Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique.
Kriegsmann M; Arens N; Endris V; Weichert W; Kriegsmann J
Diagn Pathol; 2015 Jul; 10():132. PubMed ID: 26220423
[TBL] [Abstract][Full Text] [Related]
6. Clinical Validation of Plasma-Based Genotyping for
Aoki Y; Nakamura Y; Denda T; Ohta T; Esaki T; Shiozawa M; Yamaguchi K; Yamazaki K; Sunakawa Y; Kato T; Okano N; Taniguchi H; Sato T; Oki E; Nishina T; Komatsu Y; Matsuhashi N; Goto M; Yasui H; Ohtsubo K; Moriwaki T; Takahashi N; Horita Y; Boku S; Wakabayashi M; Ikeno T; Mitani R; Yuasa M; Yoshino T
JCO Precis Oncol; 2023 Jun; 7():e2200688. PubMed ID: 37343204
[TBL] [Abstract][Full Text] [Related]
7. Deep neural network for the prediction of KRAS, NRAS, and BRAF genotypes in left-sided colorectal cancer based on histopathologic images.
Li X; Chi X; Huang P; Liang Q; Liu J
Comput Med Imaging Graph; 2024 Jul; 115():102384. PubMed ID: 38759471
[TBL] [Abstract][Full Text] [Related]
8. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer.
Miyamoto Y; Suyama K; Baba H
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368335
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience.
Gong J; Cho M; Sy M; Salgia R; Fakih M
Oncotarget; 2017 Jun; 8(26):42198-42213. PubMed ID: 28178681
[TBL] [Abstract][Full Text] [Related]
11. ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.
Forthun RB; Hovland R; Schuster C; Puntervoll H; Brodal HP; Namløs HM; Aasheim LB; Meza-Zepeda LA; Gjertsen BT; Knappskog S; Straume O
Sci Rep; 2019 Nov; 9(1):17471. PubMed ID: 31767937
[TBL] [Abstract][Full Text] [Related]
12. Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.
Yamazaki K; Taniguchi H; Yoshino T; Akagi K; Ishida H; Ebi H; Nakatani K; Muro K; Yatabe Y; Yamaguchi K; Tsuchihara K
Cancer Sci; 2018 Jun; 109(6):2074-2079. PubMed ID: 29873882
[TBL] [Abstract][Full Text] [Related]
13. Resolving Discrepancies in Idylla
George GV; Liu H; Jajosky AN; Oltvai ZN
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790156
[No Abstract] [Full Text] [Related]
14. The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer.
Ursem C; Venook AP
Oncology (Williston Park); 2017 Nov; 31(11):785-8, 802. PubMed ID: 29179247
[TBL] [Abstract][Full Text] [Related]
15.
Fei F; Caporale C; Chang L; Fortini BK; Ali H; Bell D; Stein A; Marcucci G; Telatar M; Afkhami M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791222
[No Abstract] [Full Text] [Related]
16. CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?
Pinto TDA; Alves TDDN; Pinto SA; Oliveira EC
Arq Bras Cir Dig; 2021; 34(1):e1574. PubMed ID: 34133521
[TBL] [Abstract][Full Text] [Related]
17. Concomitant Non-V600E BRAF and KRAS Mutations in Colorectal Carcinoma by Next-Generation Sequencing: A Distinct Subtype.
Srivastava P; Mishra S; Shukla S; Sharma P; Husain N
Int J Surg Pathol; 2023 Dec; ():10668969231215425. PubMed ID: 38086758
[TBL] [Abstract][Full Text] [Related]
18. BRAF-mutated metastatic colorectal cancer between past and future.
Cremolini C; Di Maio M; Petrelli F; Berenato R; Loupakis F; Pietrantonio F
Br J Cancer; 2015 Dec; 113(11):1634-5. PubMed ID: 26355234
[No Abstract] [Full Text] [Related]
19. Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population.
Nindra U; Pal A; Lea V; Lim SH; Wilkinson K; Asghari R; Roberts TL; Becker TM; Farzin M; Rutland T; Lee M; MacKenzie S; Ng W; Wang B; Lee CS; Chua W
PLoS One; 2023; 18(10):e0292087. PubMed ID: 37796807
[TBL] [Abstract][Full Text] [Related]
20. Extended Enrichment for Ultrasensitive Detection of Low-Frequency Mutations by Long Blocker Displacement Amplification.
Si Y; Wang X; Su X; Weng Z; Hu Q; Li Q; Fan C; Zhang DY; Wang Y; Luo S; Song P
Angew Chem Int Ed Engl; 2024 May; 63(19):e202400551. PubMed ID: 38416545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
